For example, overexpression of CCT2 could promote triple-negative breast cancer cell chemoresistance and cell migration and invasion via the AKT/GSK3β/β-catenin and XIAP/Survivin pathways (26). Here, BIRC5 is linked to triple-negative breast carcinoma.